Guiding Principles for Recovering, Building Resiliency, and Strengthening of Immunisation in 2022 and Beyond

LOOK AT THIS IF YOU'RE INTERESTED IN:

Understanding global recommendations for recovering, building resiliency, and strengthening of immunisation programmes.

HOW YOU CAN USE THIS MATERIAL:

These guiding principles should be used by country decision-makers in their decision-making and actions regarding immunisation recovery, resiliency, and strengthening of immunisation programmes in the context of the COVID-19 pandemic, including COVID-19 vaccination introduction and scale-up, and support efforts toward pandemic preparedness and building global health security.

OVERVIEW:

Countries are encouraged to urgently close immunity gaps and recover immunisation services while capitalizing on the opportunities from the pandemic response and COVID-19 vaccine roll-out. These guiding principles intend to support countries in their decision-making and actions regarding immunisation recovery, resiliency, and strengthening of immunisation programmes in the context of the COVID-19 pandemic, including COVID-19 vaccination introduction and scale-up, and support efforts toward pandemic preparedness and building global health security.

You May Also Like

Linked Country Case Study: Strengthening Indonesia’s National Immunisation Program

The Linked Immunisation Action Network has supported Indonesia in addressing critical immunisation challenges through peer-to-peer learning and tailored interventions. Amidst COVID-19-related backsliding (DTP3 coverage dropped from 85% in 2019 to 67% in 2021), Indonesia engaged in collaborative learning exchanges to tackle human resource gaps, data system limitations, and subnational inequities. Key initiatives included a study … Read More

Download
File size: 4.54M

Socioeconomic-related inequities in child immunisation: horizontal and vertical dimensions for policy insights

A study in Health Economics Review investigates the economic and equity impacts of expanding immunisation programs in low- and middle-income countries (LMICs), focusing on the cost-effectiveness of introducing new vaccines. The research highlights that while scaling up immunisation efforts requires significant investment, the long-term benefits—such as reduced disease burden, healthcare savings, and improved productivity—justify the … Read More